Another study on 96 fresh frozen ovarian cancer tissues obtained from chemotherapy-naïve patients and patients after neoadjuvant chemotherapy was performed using a tailored NanoString-based Pancancer Pathway Panel of 19 HR genes and showed a correlation between over-expression of C11osf30, NBN, FANCF, FANCC, FANCB, RAD50 and improved outcome in chemotherapy-naïve patients. The gene discussed is FANCF; the disease is ovarian carcinoma.